Desjardins Global Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $1.67M | Buy |
32,615
+156
| +0.5% | +$8K | 0.18% | 135 |
|
|
2023
Q3 | $1.88M | Buy |
32,459
+1,111
| +4% | +$64.5K | 0.21% | 106 |
|
|
2023
Q2 | $2M | Buy |
31,348
+5,189
| +20% | +$332K | 0.23% | 94 |
|
|
2023
Q1 | $1.81M | Buy |
26,159
+6,215
| +31% | +$431K | 0.23% | 95 |
|
|
2022
Q4 | $1.44M | Sell |
19,944
-2,451
| -11% | -$176K | 0.23% | 99 |
|
|
2022
Q3 | $1.59M | Buy |
22,395
+444
| +2% | +$31.5K | 0.2% | 104 |
|
|
2022
Q2 | $1.69M | Buy |
21,951
+5,617
| +34% | +$432K | 0.22% | 105 |
|
|
2022
Q1 | $1.19M | Sell |
16,334
-2,504
| -13% | -$183K | 0.1% | 181 |
|
|
2021
Q4 | $1.17M | Buy |
+18,838
| New | +$1.17M | 0.1% | 186 |
|